These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 7511302

  • 1. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H, Remberger K.
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [Abstract] [Full Text] [Related]

  • 2. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H, Remberger K.
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [Abstract] [Full Text] [Related]

  • 3. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I, Schelling KH, Adams JY, Merk FB, Alroy J.
    Prostate; 2001 May 15; 47(3):149-63. PubMed ID: 11351344
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J, Arnold JT, Isaacs JT.
    Cancer Res; 2001 Jul 01; 61(13):5038-44. PubMed ID: 11431338
    [Abstract] [Full Text] [Related]

  • 6. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F, Chapdelaine A, Bégin LR, Chevalier S.
    J Urol; 1996 Jan 01; 155(1):386-90. PubMed ID: 7490893
    [Abstract] [Full Text] [Related]

  • 7. Stem/progenitor and intermediate cell types and the origin of human prostate cancer.
    Tokar EJ, Ancrile BB, Cunha GR, Webber MM.
    Differentiation; 2005 Dec 01; 73(9-10):463-73. PubMed ID: 16351690
    [Abstract] [Full Text] [Related]

  • 8. Unique features of the basal cells of human prostate epithelium.
    El-Alfy M, Pelletier G, Hermo LS, Labrie F.
    Microsc Res Tech; 2000 Dec 01; 51(5):436-46. PubMed ID: 11074614
    [Abstract] [Full Text] [Related]

  • 9. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationship: new perspectives.
    Xue Y, Smedts F, Verhofstad A, Debruyne F, de la Rosette J, Schalken J.
    Prostate Suppl; 1998 Dec 01; 8():62-73. PubMed ID: 9690665
    [Abstract] [Full Text] [Related]

  • 10. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG, Gardner WA.
    Med Hypotheses; 2008 Dec 01; 70(2):387-408. PubMed ID: 17658698
    [Abstract] [Full Text] [Related]

  • 11. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR.
    Pathologica; 1994 Apr 01; 86(2):128-41. PubMed ID: 7524011
    [Abstract] [Full Text] [Related]

  • 12. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H.
    Prostate Suppl; 1998 Apr 01; 8():18-22. PubMed ID: 9690659
    [Abstract] [Full Text] [Related]

  • 13. Hormone regulation of human prostate in organ culture.
    Nevalainen MT, Härkönen PL, Valve EM, Ping W, Nurmi M, Martikainen PM.
    Cancer Res; 1993 Nov 01; 53(21):5199-207. PubMed ID: 7693334
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H, Stein U, Aumüller G, Remberger K.
    Prostate; 1996 Oct 01; 29(4):261-7. PubMed ID: 8876709
    [Abstract] [Full Text] [Related]

  • 15. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U, McNamara K, Gao YR, Handelsman DJ.
    Am J Physiol Endocrinol Metab; 2009 Jun 01; 296(6):E1335-43. PubMed ID: 19366880
    [Abstract] [Full Text] [Related]

  • 16. Clonal architecture of human prostatic epithelium in benign and malignant conditions.
    Gaisa NT, Graham TA, McDonald SA, Poulsom R, Heidenreich A, Jakse G, Knuechel R, Wright NA.
    J Pathol; 2011 Oct 01; 225(2):172-80. PubMed ID: 21898875
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P, Royuela, Bethencourt R, Ruiz A, Fraile B, Paniagua R.
    Cytokine; 1999 Sep 01; 11(9):722-7. PubMed ID: 10479409
    [Abstract] [Full Text] [Related]

  • 18. [Immunohistochemistry of the prostate and prostate carcinomas].
    Wernert N.
    Veroff Pathol; 1991 Sep 01; 135():1-163. PubMed ID: 2038892
    [Abstract] [Full Text] [Related]

  • 19. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T, Müller-Huesmann H, Riedel M, Kehlen A, Bialek J, Radestock Y, Holzhausen HJ, Steger K, Ludwig M, Weidner W, Hoang-Vu C, Hombach-Klonisch S.
    Int J Oncol; 2005 Aug 01; 27(2):307-15. PubMed ID: 16010410
    [Abstract] [Full Text] [Related]

  • 20. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM, Meeker AK, Epstein JI, Coffey DS.
    Am J Pathol; 1998 Sep 01; 153(3):911-9. PubMed ID: 9736039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.